(1R,2R)-2-Phenylcyclopropanecarboxylic acid, 97%, 100mg

6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)thiazolo[5,4-b]pyridine, 97%, 250mg

N,N-DIMETHYL-3-MORPHOLINOPROPAN-1-AMINE, 95.0%, 250mg

Dialysis membrane Spectra/Por® 1 to 4 Spectra/Por® 4 - MWCO 12,000 to 14,000, 10 mm, 30 m, 1 Piece(s)

4-ETHOXY-1H-INDOLE-3-CARBALDEHYDE, 97%, 100mg

N-Acetylhistamine, 99.79%, 1g

3-Bromo-4-iodoaniline, 95.0%, 1g

(R)-METHYL 2-AMINO-2-(2-CHLOROPHENYL)ACETATE HYDROCHLORIDE, 95%, 5g

2-(7H-Pyrrolo[2,3-d]pyrimidin-4-yl)isoindoline-1,3-dione, 95.0%, 10g

6-Chloro-2-methyl-quinoline-4-carboxylic acid, 95.0%, 5g

N-(tert-Butoxycarbonyl)-S-trityl-L-cysteine>98.0%(HPLC)(T)5g

((Allyloxy)methyl)benzene, 95.0%, 25g

Tetramethylene Glycol Monovinyl Ether (stabilized with KOH)>97.0%(GC)25mL